
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
Changes in compounding standards take effect on June 1, 2008
USP has revised its standards and conditions for sterile compounding in order to improve patient safety. Changes to General Chapter Pharmaceutical Compounding-Sterile Preparations have been posted on-line on USP's Web site (






